Selera-2 was chosen as the best model designed for its physico-chemical and structural properties and was submitted to docking analysis with therapeutic targets.<h4>Results and discussion</h4>Docking models of B-RAF and TrxR1 demonstrated to be the most stable binding sites, considering low-binding energy levels and molecular dynamics profile, suggesting possible targets for anti tumor effect. The gene discussed is BRAF; the disease is neoplasm.